What should the dental hygienist do first if a patient reports a suspected adverse drug effect?

  1. Allergy UK. Anaphylaxis and severe allergic reaction. 2020. Available at https://www.allergyuk.org/information-and-advice/conditions-and-symptoms/33-anaphylaxis-and-severe-allergic-reaction (accessed May 2020).

  2. Jevon P. Basic Guide to Medical Emergencies in the Dental Practice. 2nd ed. Oxford: Wiley, 2013.

  3. GDC. Standards for the dental team. 2013. Available at https://standards.gdc-uk.org/Assets/pdf/Standards%20for%20the%20Dental%20Team.pdf (accessed May 2020).

  4. Resuscitation Council UK. Emergency treatment of anaphylactic reactions: Guidelines for healthcare providers. 2017. Available online at https://www.resus.org.uk/library/additional-guidance/guidance-anaphylaxis/emergency-treatment (accessed May 2020).

  5. Department of Health & Social Care. Supply Disruption Alert: SDA/2018/001 - EpiPen and EpiPen Junior (adrenaline auto-injector devices). 2018. Available online at https://www.cas.mhra.gov.uk/ViewandAcknowledgment/ViewAttachment.aspx?Attachment_id=103102 (accessed May 2020).

  6. MHRA. Adrenaline auto-injectors: recent action taken to support safety. 2019. Available online at https://www.gov.uk/drug-safety-update/adrenaline-auto-injectors-recent-action-taken-to-support-safety (accessed November 2020).

  7. MHRA. Class 2 Medicines Recall: Emerade 300 micrograms solution for injection in pre-filled syringe, PL 33616/0014 (EL(20)A/20). 2020 Available at https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-emerade-300-micrograms-solution-for-injection-in-pre-filled-syringe-pl-33616-0014-el-20-a-20 (accessed May 2020).

  8. MHRA. Patients informed to exchange Emerade 500 micrograms adrenaline pens for a different brand. 2020. Available at https://www.gov.uk/government/news/patients-informed-to-exchange-emerade-500-micrograms-adrenaline-pens-for-a-different-brand (accessed May 2020).

  9. Office of Chief Dental Officer England. Adrenaline for anaphylaxis kits - a reminder to Health Care Professionals. 2018. Available at http://www.bsdht.org.uk/News/20181009%20-%20EpiPen%20Advice%20-%20CDO%20England%20Final.pdf (accessed May 2020).

  10. Department of Health & Social Care. Supply Disruption Alert: SDA/2019/004 - Emerade 500 microgram and 300 microgram adrenaline auto-injector devices. 2019. Available at https://www.cas.mhra.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=102885 (accessed May 2020).

  11. NICE. Angio-ooedema and anaphylaxis. 2018.Available online at https://cks.nice.org.uk/topics/angio-oedema-anaphylaxis/ (accessed April 2020).

  12. Turner P J, Gowland M H, Sharma V et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012. J Allergy Clin Immunol 2015; DOI: 10.1016/j.jaci.2014.10.021.

  13. Anaphylaxis Campaign. Drug Allergy: The Facts. 2017. Available at https://www.anaphylaxis.org.uk/wp-content/uploads/2019/07/Drug-Allergy-2017.pdf (accessed May 2020).

  14. SDCEP. Drugs for the Management of Dental Problems During COVID-19 Pandemic. 2020. Available at https://www.sdcep.org.uk/wp-content/uploads/2020/05/SDCEP-MADP-COVID-19-drug-supplement-update-110520.pdf (accessed May 2020).

  15. Pumphrey R S H. Fatal anaphylaxis in the UK, 1992-2001. Novartis Found Symp 2004; 257: 116-128; discussion 128-132, 157-160, 276-285.

  16. Harper N, Cook T, Garcez T et al. Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6). Br J Anaesth 2018; 121: 159-171.

  17. Cloitre A, Duval X, Tubiana S et al. Antibiotic prophylaxis for the prevention of infective endocarditis for dental procedures is not associated with fatal adverse drug reactions in France. Med Oral Patol Oral Cir Bucal 2019; DOI: 10.4317/medoral.22818.

  18. Pemberton M N. Allergy to chlorhexidine. Dent Update 2016; 43: 272-274.

  19. Anaphylaxis Campaign. Chlorhexidine. 2019 Available at https://www.anaphylaxis.org.uk/knowledgebase/chlorhexidine/ (accessed May 2020).

  20. MHRA. All medical devices and medicinal products containing chlorhexidine - Risk of anaphylactic reaction due to chlorhexidine allergy. 2014.Available at https://www.gov.uk/drug-device-alerts/medical-device-alert-all-medical-devices-and-medicinal-products-containing-chlorhexidine-risk-of-anaphylactic-reaction-due-to-chlorhexidine-allergy (accessed May 2020).

  21. BBC News. Mouthwash reaction killed Brighton dental patient. 2011. Available at https://www.bbc.co.uk/news/uk-england-sussex-14951073 (accessed May 2020).

  22. Whitehaven News. Mouthwash linked to death of patient, 63. 2011. Available at https://www.whitehavennews.co.uk/news/17135703.mouthwash-linked-to-death-of-patient-63/ (accessed May 2020).

  23. Harper N J N, Dixon T, Dugue P et al. Guidelines: Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 2009; 64: 199-211.

  24. SDCEP. Management of Acute Dental Problems: Guidance for healthcare professionals. 2013. Available at https://www.sdcep.org.uk/wp-content/uploads/2013/03/SDCEP+MADP+Guidance+March+2013.pdf (accessed May 2020).

  25. SDCEP. Management of Acute Dental Problems during COVID-19. 2020. Available at https://www.sdcep.org.uk/wp-content/uploads/2020/03/SDCEP-MADP-COVID-19-guide-300320.pdf (accessed May 2020).

  26. NHS, Specialist Pharmacy Service and UK Medicines Information. Allergy to local anaesthetic agents used in dentistry - what are the signs, symptoms, alternative diagnoses and management options? 2019. Available at https://www.sps.nhs.uk/wp-content/uploads/2019/08/UKMi_QA_Dental-local-anaesthetic-allergy-update_May-2019.pdf (accessed May 2020).

  27. Lee J, Lee J-Y, Kim H J, Seo K-S. Dental anaesthesia for patients with allergic reactions to lidocaine: two case reports. J Dent Anesth Pain Med 2016; 16: 209-212.

  28. Gu J Q, Liu S, Zhi Y X. Provocation Test-confirmed chlorhexidine-induced anaphylaxis in dental procedure. Chin Med J (Engl) 2018; 131: 2893-2894.

  29. Kim H, Lee J M, Seo K S, Kwon S M, Row H S. Anaphylactic reaction after local lidocaine infiltration for retraction of retained teeth. J Dent Anesth Pain Med 2019; 19: 175-180.

  30. Fisher M M, Bowey C J. Alleged allergy to local anaesthetics. Anaesth Intensive Care 1997; 25: 611-614.

  31. Batinac T, Sotošek Tokmadžić V, Peharda V, Brajac I. Adverse reactions and alleged allergy to local anaesthetics: analysis of 331 patients. J Dermatol 2013; 40: 522-527.

  32. Renton T. Inferior Dental Blocks Versus Infiltration Dentistry: Is it time for change? Dent Update 2019; 46: 204-218.

  33. Becker D E. Drug allergies and implications for dental practice. Anesth Prog 2013; 60: 188-197.

  34. Wildsmith J A W, Mason A, McKinnon R P et al. Alleged allergy to local anaesthetic drugs. Br Dent J 1998; 184: 507-510.

  35. Sinclair E. Are you allergic to latex? BDJ Team 2017; DOI: 10.1038/bdjteam.2017.41.

  36. Baluga J C, Casamayou R, Carozzi E et al. Allergy to local anaesthetics in dentistry. Myth or reality? Allergol Immunopathol (Madr) 2002; 30: 14-19.

  37. The Australian Dental Association. Available online at https://www.ada.org.au/ (accessed October 2020).

  38. Anaphylaxis Campaign. Latex allery: the facts. 2019. Available at https://www.anaphylaxis.org.uk/knowledgebase/latex-allergy-the-facts/ (accessed May 2020).

  39. Health and Safety Executive. Latex allergy in health and social care. 2019. Available at https://www.hse.gov.uk/healthservices/latex/ (accessed May 2020).

  40. Wu M, McIntosh J, Liu J. Current prevalence rate of latex allergy: Why it remains a problem? J Occup Health 2016; 58: 138-144.

  41. British Association of Dermatologists. Latex allergy. 2017. Available at https://www.bad.org.uk/shared/get-file.ashx?id=4349&itemtype=document (accessed May 2020).

  42. Pumphrey R S, Duddridge M, Norton J. Fatal latex allergy. J Allergy Clin Immunol 2001; 107: 558.

  43. Chin S M, Ferguson J W, Bajurnow T. Latex allergy in dentistry. Review and report of case presenting as a serious reaction to latex dental dam. Aust Dent J 2004; 49: 146-148.

  44. Hamann C, Turjanmaa K, Rietschel R et al. Natural rubber latex hypersensitivity: incidence and prevalence of type I allergy in the dental professional. J Am Dent Assoc 1998; 129: 43-54.

  45. Anaphylaxis Campaign. Dental Practice: Management of a patient with Type 1 NRL allergy. 2019. Available at https://www.anaphylaxis.org.uk/hcp/natural-rubber-latex-nrl/dental-practice/ (accessed May 2020).

  46. Anaphylaxis Campaign. Latex Allergy and the Law. 2019. Available at https://www.anaphylaxis.org.uk/living-with-anaphylaxis/living-with-natural-rubber-nrl-allergy/the-law/ (accessed May 2020).

  47. Paiva M, Piedade S, Gaspar A. Toothpaste-induced anaphylaxis caused by mint (Mentha) allergy. Allergy 2010; 65: 1196-1204.

  48. Smith G. After Daughter's Fatal Reaction to Toothpaste, Mother Calls for Caution. Allergic Living 2019. Available at https://www.allergicliving.com/2019/04/15/after-daughters-fatal-reaction-to-toothpaste-mother-calls-for-caution/ (accessed November 2020).

  49. Kekatos M. Girl, 11, dies after a severe allergic reaction to toothpaste that contained a milk protein. Daily Mail (London) 2019 April 18.

  50. Australian Dental Association. Allergy: A dental cautionary tale. 2019 Available at https://www.ada.org.au/News-Media/News-and-Release/Latest-News/Allergy-A-dental-cautionary-tale (accessed May 2020).

  51. Darvell B. Materials Science for Dentistry. 10th ed. London: Elsevier, 2018.

  52. Septodont. Alvogyl patient information leaflet. 2006. Available at https://www.septodont.co.uk/sites/default/files/Alvogyl%20Patient%20information%20leaflet%20S%2005%2006%20047%2011%2000.pdf (accessed May 2020).

  53. Webb L, Greene E, Lieberman P L. Anaphylaxis: a review of 593 cases. J Allergy Clin Immunol 2004; 113: S240.

  54. Song T T, Lieberman P. Adrenaline in anaphylaxis: doubt no more. Curr Opin Allergy Clin Immunol 2015; 15: 323-328.

  55. Chooniedass R, Temple B, Becker A. Adrenaline use for anaphylaxis: too seldom, too late: current practices and guidelines in health care. Ann Allergy Asthma Immunol 2017; 119: 108-110.

  56. Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol 2005; 95: 217-226.

  57. Storey P, Fitzharris P. Adrenaline in anaphylaxis: overtreatment in theory, undertreatment in reality. Postgrad Med J 2015; 91: 1-2.

  58. Electronic Medicines Compendium.Adrenaline (Adrenaline) 1mg/ml (1:1000) solution for injection. Available online at https://www.medicines.org.uk/emc/product/3673/smpc (accessed May 2020).

  59. NICE. British National Formulary. Available online at https://bnf.nice.org.uk/ (accessed May 2020).

  60. Anaphylaxis Campaign. Anaphylaxis: the facts. 2019. Available at https://www.anaphylaxis.org.uk/wp-content/uploads/2019/07/Anaphylaxis-The-Facts-Feb-2019.pdf (accessed May 2020).

  61. Cameron R, Little M, Mitra B, Deasy C. Textbook of Adult Emergency Medicine. 5th ed. London: Elsevier, 2019.

  62. Roth J V, Shields A. A dilemma: how does one treat anaphylaxis in the sulphite allergic patient since Adrenaline contains sodium metabisulphite? Anesth Analg 2004; DOI: 10.1213/01.ane.0000120092.39021.f2.

  63. Australian Society of Clinical Immunology and Allergy. Sulfite Sensitivity. 2019. Available at https://www.allergy.org.au/patients/other-allergy/sulfite-allergy (accessed May 2020).

  64. Anaphylaxis Campaign. Sulphites. 2019. Available at https://www.anaphylaxis.org.uk/wp-content/uploads/2019/11/Sulphites-2019.pdf (accessed May 2020).

  65. Food Allergy Canada. Sulphites. 2020. Available at https://foodallergycanada.ca/food-allergy-basics/food-allergies-101/what-are-food-allergies/sulphites/ (accessed November 2020).

  66. Ewan P, Brathwaite N, Leech S et al. BSACI guideline: prescribing an adrenaline auto-injector. Clin Exp Allergy 2016; 46: 1258-1280.

  67. Courts and Tribunal Judiciary. Regulation 28: Report to prevent further deaths. 2018. Available at https://www.judiciary.uk/wp-content/uploads/2018/10/Natasha-LAPEROUSE-2018-0279.pdf (accessed May 2020).

  68. Travers A, Taylor K. Adrenaline use: The use of pre-filled adrenaline syringes in anaphylaxis kits. Br Dent J 2019; 226: 85.

  69. Public Health England. Immunisation against infectious diseases. 2014. Available online at https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book (accessed April 2020).

  70. Health and Safety Executive. Health and Safety (Sharp Instruments in Healthcare) Regulations 2013: Guidance for employers and employees. 2013. Available online at https://www.hse.gov.uk/pubns/hsis7.htm (accessed May 2020).

  71. Shepherd E. Injection technique 1: administering drugs via the intramuscular route. Nurs Times 2018; 114: 23-25.

  72. Song T T, Nelson M R, Chang J H, Engler R J, Chowdhury B A. Adequacy of the Adrenaline autoinjector needle length in delivering adrenaline to the intramuscular tissues. Ann Allergy Asthma Immunol 2005; 94: 539-542.

  73. World Health Organisation. WHO guidelines on Hand Hygiene in Healthcare: a summary. 2009. Available at https://www.who.int/gpsc/5may/tools/who_guidelines-handhygiene_summary.pdf (accessed May 2020).

  74. Greenway K. Rituals in Nursing: intramuscular injection. J Clin Nurs 2014; DOI: 10.1111/jocn.12627.

  75. Dougherty L, Lister S. The Royal Marsden Hospital Manual of Clinical Nursing Procedures. Oxford: Wiley-Blackwell, 2015.

  76. Weenig C S. A better, safer, and inexpensive way to open glass ampules. Anaesthesiology 1998; 88: 838.

  77. University of Bristol. How to open a glass vial. 2018. Available at http://www.bristol.ac.uk/media-library/sites/vetscience/documents/clinical-skills/How%20to%20Open%20a%20Glass%20Vial.pdf (accessed November 2020).

  78. ACT Academy. SBAR communication tool - situation, background, assessment, recommendation. 2018. Available at https://improvement.nhs.uk/documents/2162/sbar-communication-tool.pdf (accessed April 2020).

  79. Maher N G, de Looze J, Hoffman G R. Anaphylaxis: an update for dental practitioners. Aust Dent J 2014; 59: 142-158.

  80. Pumphrey R S. Fatal posture in anaphylactic shock. J Allergy Clin Immunol 2003; 112: 451-452.

  81. CQC. Dental mythbuster 8: Dental care records. 2018. Available at https://www.cqc.org.uk/guidance-providers/dentists/dental-mythbuster-8-dental-care-records (accessed April 2020).

  82. MHRA. Yellow card. Available online at https://yellowcard.mhra.gov.uk/ (accessed April 2020).

  83. CQC. Dental mythbuster 11: Statutory notifications to CQC. 2020. Available at https://www.cqc.org.uk/guidance-providers/dentists/dental-mythbuster-11-statutory-notifications-cqc (accessed April 2020).


Page 2

British Dental Journal (Br Dent J) ISSN 1476-5373 (online) ISSN 0007-0610 (print)